Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems.
Saved in:
| Title: | Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems. |
|---|---|
| Authors: | Ross TT; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Crowley C; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Kelly KL; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Rinaldi A; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Beebe DA; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Lech MP; Inflammation and Immunology Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Martinez RV; Inflammation and Immunology Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Carvajal-Gonzalez S; Early Clinical Development, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Boucher M; Drug Safety Research and Development, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Hirenallur-Shanthappa D; Comparative Medicine, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Morin J; Comparative Medicine, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Opsahl AC; Drug Safety Research and Development, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Vargas SR; Drug Safety Research and Development, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Bence KK; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Pfefferkorn JA; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts., Esler WP; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts. Electronic address: William.Esler@Pfizer.com. |
| Source: | Cellular and molecular gastroenterology and hepatology [Cell Mol Gastroenterol Hepatol] 2020; Vol. 10 (4), pp. 829-851. Date of Electronic Publication: 2020 Jun 09. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Gastroenterological Association Country of Publication: United States NLM ID: 101648302 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-345X (Electronic) Linking ISSN: 2352345X NLM ISO Abbreviation: Cell Mol Gastroenterol Hepatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32526482 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ross+TT%22">Ross TT</searchLink>; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Crowley+C%22">Crowley C</searchLink>; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Kelly+KL%22">Kelly KL</searchLink>; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Rinaldi+A%22">Rinaldi A</searchLink>; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Beebe+DA%22">Beebe DA</searchLink>; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Lech+MP%22">Lech MP</searchLink>; Inflammation and Immunology Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Martinez+RV%22">Martinez RV</searchLink>; Inflammation and Immunology Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Carvajal-Gonzalez+S%22">Carvajal-Gonzalez S</searchLink>; Early Clinical Development, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Boucher+M%22">Boucher M</searchLink>; Drug Safety Research and Development, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Hirenallur-Shanthappa+D%22">Hirenallur-Shanthappa D</searchLink>; Comparative Medicine, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Morin+J%22">Morin J</searchLink>; Comparative Medicine, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Opsahl+AC%22">Opsahl AC</searchLink>; Drug Safety Research and Development, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Vargas+SR%22">Vargas SR</searchLink>; Drug Safety Research and Development, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Bence+KK%22">Bence KK</searchLink>; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Pfefferkorn+JA%22">Pfefferkorn JA</searchLink>; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts.<br /><searchLink fieldCode="AU" term="%22Esler+WP%22">Esler WP</searchLink>; Internal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge Massachusetts. Electronic address: William.Esler@Pfizer.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101648302%22">Cellular and molecular gastroenterology and hepatology</searchLink> [Cell Mol Gastroenterol Hepatol] 2020; Vol. 10 (4), pp. 829-851. <i>Date of Electronic Publication: </i>2020 Jun 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Gastroenterological+Association%22">American Gastroenterological Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101648302 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2352-345X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222352345X%22">2352345X </searchLink><i>NLM ISO Abbreviation: </i>Cell Mol Gastroenterol Hepatol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32526482 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jcmgh.2020.06.001 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 829 Titles: – TitleFull: Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model Systems. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ross TT – PersonEntity: Name: NameFull: Crowley C – PersonEntity: Name: NameFull: Kelly KL – PersonEntity: Name: NameFull: Rinaldi A – PersonEntity: Name: NameFull: Beebe DA – PersonEntity: Name: NameFull: Lech MP – PersonEntity: Name: NameFull: Martinez RV – PersonEntity: Name: NameFull: Carvajal-Gonzalez S – PersonEntity: Name: NameFull: Boucher M – PersonEntity: Name: NameFull: Hirenallur-Shanthappa D – PersonEntity: Name: NameFull: Morin J – PersonEntity: Name: NameFull: Opsahl AC – PersonEntity: Name: NameFull: Vargas SR – PersonEntity: Name: NameFull: Bence KK – PersonEntity: Name: NameFull: Pfefferkorn JA – PersonEntity: Name: NameFull: Esler WP IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2020 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 2352-345X Numbering: – Type: volume Value: 10 – Type: issue Value: 4 Titles: – TitleFull: Cellular and molecular gastroenterology and hepatology Type: main |
| ResultId | 1 |